HNHamed Naghoosi

Hamed Naghoosi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hamed Naghoosi has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Mohammad Reza Zali

    Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran

    5 shared publications
  • Sara Romani

    Gastroenterology and Liver Diseases Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    5 shared publications
  • Pedram Azimzadeh

    Gastroenterology and Liver Diseases Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    4 shared publications
  • Seyed Reza Mohebbi

    Gastroenterology and Liver Diseases Research center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Azar Sanati

    Gastroenterology and Liver Diseases Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    2 shared publications
  • Behzad Damavand

    Gastroenterology and Liver Diseases Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    2 shared publications

Latest Publications

  • Biodegradation of human faecal sludge for photosynthetic bioelectricity generation and seawater desalination in a microbial desalination cell

    by Soroosh Danaee, Hamed Naghoosi, Neda Badali Varzaghani, Phong H. N. Vo

    Inaccessibility and expensiveness of vital infrastructures are the main problems in some urban and rural areas to supply fresh water, sustainable energy, and wastewater treatment. An effective solution is the integration of several systems in an environmentally friendly technology of the photosynthetic microbial desalination cell (PMDC). The aim of this study is to assess the process characterization of an algae-based PMDC, which was loaded with a high-strength mixture of human feces and urine (HFS). The PMDC was also able to efficiently remove COD and total nitrogen of HFS by 50% and 94%, respectively. The maximum power density, voltage, and desalination efficiency of 362.5 mW/m², 175.2 mV, and 60% were accomplished. Adequate parameter adjustment led to a remarkable maximum of 2.25 g/L.d in the ion removal rate. In addition, an energy balance was governed showing that zero or positive net energy in PMDC is feasible by replacing the main energy consumers. Based on the results, this type of MDC had a high efficiency for simultaneous saline water desalination and HFS treatment, which makes it attractive for further studies of upscaling and its application in remote areas.


  • Open Access

    Monkeypox: A Re-emerging Viral Zoonotic Infection

    by Seyyed-Javad Hosseini-Shokouh, Mohammad Gholami, Mohammad Barati, Hamed Naghoosi

    Context: Monkeypox virus (MPXV) infection is a zoonotic disease, endemic in sub-Saharan Africa, but recently has re-emerged outside Africa and caused some concerns. Evidence Acquisition: The current study aimed to briefly present a narrative mini-review on different features of MPXV. Data were gathered from Google Scholar, ScienceDirect, and PubMed databases and also WHO and CDC websites, using ''Monkeypox'', ''Variola'', ''Bioterrorism'', and ''Bioweapon'' keywords. Results: Monkeypox virus is categorized into two genetic clades with different outcomes. The incubation period of infection is 5 - 21 days, and infection by Central African clade may lead to a clinical representation similar to smallpox with about 10% mortality rate. Monkeypox virus can infect a wide range of mammals, and its natural reservoir is almost unknown. It is endemic in sub-Saharan Africa and is rarely seen outside Africa. Its most reliable detection is based on nucleic acid amplification tests (NAATs). Treatment is mainly supportive, and some selective drugs are developed for severe cases. Avoiding close contact with wild animals and infected patients is the first line of prevention. Prior vaccination with smallpox or MPX vaccines is also protective. Due to similar symptoms of human monkeypox and smallpox, it may be a candidate for bioterrorism. However, there is no evidence of recent intentional spread of MPXV. Conclusions: This study has tried to provide a summary of MPXV infection. Despite recent concerns, there is still a very low risk of the MPXV pandemic. However, it is recommended to be alert for such infection and provide essential readiness against it.

  • Open Access

    Evaluation of Mutation in Spike Gene of Covid-19 in Iranian Patients

    by Mohammad Gholami, Negin Hosseini Rouzbahani, Hamed Naghoosi, Sajad Fani-Kheshti, Seyyed-Javad Hosseini-Shokouh

    : SARS-COV- 2, originated at Wuhan (China), has spread rapidly worldwide. Mutant variants have been identified in various countries. In this study, samples of 18 Covid-19 cases in the third wave and 25 in the fourth wave of the epidemic in Iran were collected and sequenced using the Sanger method. The results showed different mutations in the third and fourth waves of the epidemic. In the fourth wave, dominant mutations were E484K, D614G, and S519F, which were previously observed in another country. This study showed that the SARS-CoV-2 genome is constantly going under changes, and evaluating and monitoring mutations in the virus genome is necessary to control and eradicate the disease.

  • Titanium dioxide nanoparticles can induce apoptosis in cancer cells

    by Hamed Naghoosi, Mohammad Ali Saremi

  • Assessment of phosphorescent paint effects on microalgae cultivation

    by Soroosh Danaee, Nima Yazdanbakhsh, Hamed Naghoosi, Ali Sheykhinejad


  • Phylogenetic analysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients

    by Faraz Salehi Moghadam, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Sara Romani, Hanieh Mirtalebi, Pedram Azimzadeh, Behzad Damavand, Hamed Naghoosi, Mahsa Khanyaghma, Azar Sanati, et al.

    Hepatitis C virus (HCV) has infected approximately 170 million people worldwide. While the seroprevalence of anti‐HCV antibody among Iranian blood donors is 0.13%, HCV infection is prevalent in 59–80% of Iranian injecting drug users. One hundred seventy‐eight anti‐HCV positive patients were referred to the Gastroenterology Department at the Taleghani Hospital (Tehran, Iran) between June 2007 and June 2012. Out of 178 samples, 142 were positive for HCV‐RNA. HCV subtypes were determined using phylogenetic analysis of the NS5B or 5′UTR/core regions. Of 142 viremic patients, 71 (50%) were infected with HCV subtype 1a, 43 (30.3%) with subtype 3a, 20 (14.1%) with subtype 1b, 3 (2.1%) with subtype 4d, 2 (1.4%) with subtype 4a, 1 (0.7%) with subtype 2b, and 1 (0.7%) with subtype 6a. Interestingly, genetic analysis of a sub‐genomic fragment from one patient identified a non‐subtypeable HCV genotype‐3 strain. There was a significant association between HCV subtype and a history of injecting drug use (P = 0.003). Subtype 3a was predominant among patients with such a history. Injecting drug use was associated with younger age (P < 0.001). HCV subtype was also significantly associated with a history of upper gastrointestinal endoscopy (P = 0.02). Subtype 1a was more frequent among patients with such a history. In addition, history of upper gastrointestinal endoscopy was significantly associated with older age (P = 0.002). In conclusion, while HCV subtype 1a is predominant among infected Iranian individuals, subtype 3a is predominant among Iranian injecting drug users. J. Med. Virol. 86:1342–1349, 2014.


  • Open Access

    Polymorphisms Within the Promoter Region of the Gamma Interferon (IFN-γ) Receptor1 Gene are Associated With the Susceptibility to Chronic HBV Infection in an Iranian Population

    by Sayyad Khanizadeh, Mehrdad Ravanshad, Seyed Reza Mohebbi, Hamed Naghoosi, Mohamad Ebrahim Tahaei, Seyed Dawood Mousavi Nasab, Sara Romani, Pedram Azymzadeh, Azar Sanati, Mohammad Reza Zali

    Polymorphisms within the Promoter Region of the Gamma Interferon (IFN-γ) Receptor1 Gene are Associated with the Susceptibility to Chronic HBV Infection in an Iranian Population - Hepatitis Monthly - - Kowsar


  • Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study

    by Seyed Reza Mohebbi, Mohammad Rostami Nejad, Seyed Mohammad Ebrahim Tahaei, Mohammad Amin Pourhoseingholi, Manijeh Habibi, Pedram Azimzadeh, Hamed Naghoosi, Peter Karayiannis, Mohammad Reza Zali

    Hepatitis A virus (HAV) and hepatitis E virus (HEV) are enteric hepatotropic viruses and their prevalence is related to the sanitary conditions of the region under investigation. There are only a few studies on the seroepidemiology of these two viruses in the general Iranian population. The purpose of this investigation was to measure the prevalence of hepatitis A and E infections in the general population. Between 2006 and 2007, a cross sectional study was performed in Tehran, Iran. Blood specimens were collected and questionnaires were filled in for 551 persons. Patient sera were tested by ELISA for anti-HEV and anti-HAV IgGs. The χ(2) test and independent t-test were used for statistical analysis and p<0.05 was considered significant. The overall seroprevalence rates of anti-HEV IgG and anti-HAV IgG were 9.3% and 90%, respectively. The prevalence of antibodies to HAV and HEV was greater among men than women and increased with age. However, there was no significant relationship between age and gender with the existence of anti- HAV and HEV IgG antibodies. Our results show the seroprevalence of HAV and HEV antibodies are high and both viruses are endemic in this region. These findings are in accordance with results obtained from previous studies. We recommend that foreign travelers to Iran are vaccinated against HAV.


    • 1 January 2012
      • Vol. 5  (2) , 84-89
    Open Access

    Molecular prevalence of JC virus in Tehran, Iran

    by Sajjad Majidizadeh Bozorgi, Seyed Mohammad Ebrahim Tahaei, Seyed Reza Mohebbi, Negar Sahba, Behzad Damavand, Sara Romani, Pedram Azimzadeh, Hamed Naghoosi, Saman Milanizadeh, Abolfazl Mohebbi, et al.

    Since data about prevalence of JC virus in Iranian population is scarce, this study was designed to evaluate the prevalence of JC virus in healthy individuals who had attended Fajr hospital and Farjam clinical laboratory in Tehran, Iran. JC virus is the causative agent of progressive multifocal encephalopathy (PML) in individuals with suppressed immune system. There are some evidences that this virus is responsible for some forms of cancers for example colorectal and gastric cancers in humans. Urine samples from 133 healthy individuals older than 18 years old were collected and after extraction of viral DNA, PCR was performed to determine the presence of virus. Results of the test and demographic data of subjects were entered into SPSS program and were analyzed by it. 71 subjects were male and 62 individuals were female. Mean age of the population was 42.23 ± 13.47. From the total number of 133 subjects, 51 (38.3%) individuals were positive for the presence of JC virus. Gender had statistically significant relationship with JC virus presence (p= 0.042). Age was not significantly related to JC virus presence status (p= 0.3). Obtained rate of JC prevalence in this study is similar to the results of studies in India and Philippine. Because of this virus's role in AIDS and the role of this virus in gastrointestinal cancers have been revealed in recent years, the more extended studies on the prevalence of this virus in different populations in Iran is necessary.